Skip to main content


Carol Ann Wallace, MD

Carol Ann Wallace, MD


On staff since July 1979

Children's Title: Division Chief

Research Center: Center for Clinical and Translational Research

"The diseases we treat are rare, so I’m always learning from my patients and my peers. I come to work each day, knowing I will have opportunities to interact with a fabulous team committed to helping our patients realize their potential. In my research to find the best treatment for childhood arthritis, I get to collaborate with an expansive network of colleagues —nationally and internationally — who are working toward the same goals. I just wish there were more pediatric rheumatologists to fulfill the need for the specialized care we provide."

Making a Difference


LaceyKennewick Washington04.09.14
After YEARS of trying to get my son diagnosed, I was sent to Seattle Children Hospital. Within a few minutes Dr Wallace had him diagnosed and had a game plan for treatment. She is professional, through and incredibly intelligent. I couldn't give her a higher recommendation!
SarahIssaquah, WA08.07.12
I grew up at Children's due to JRA, and I dreaded the day that I turned eighteen because it meant Dr. Wallace would no longer be my rheumatologist. I can’t recommend her highly enough!
DianeAuburn, WA08.06.12
After searching for a year for a doctor that could correctly diagnose my daughter's symptoms, Dr. Wallace was able to simply look at my 11-year old daugter and diagnose scleroderma. It was a relief to work with such a seasoned professional. My daughter loved her -- which was good because we saw her frequently. Dr. Wallace was aggressive in her treatment but that was always carefully weighed by what was best for my child and what would allow her to lead a normal life. We saw Dr. Wallace from 1999-2005. By then her scleroderma was in remission. My daughter is now married with two children. Dr. Wallace, thank you for all you did for Marie and for our family. God bless you.
Dr. Wallace is my standard for judging my relationship with other doctors. Her knowledge, patients, and demeanor show that she is passionate not only about the information, but her patients as well. I feel well informed and that we couldn't be in better hands.
Recommend Dr. Carol Wallace


Board Certification(s)
Pediatric Rheumatology
Medical/Professional School
University of Michigan Medical School, Ann Arbor
Pediatrics, University of Washington School of Medicine, Seattle
Reproductive Endocrinology, University of Washington School of Medicine, Seattle
Pediatric Rheumatology, University of Washington School of Medicine, Seattle
Research Focus Area

Translational Research, Aggressive Treatment of Juvenile Idiopathic Arthritis

Awards and Honors

Award NameAward DescriptionAwarded ByAward Date
SEATTLE MAGAZINE TOP DOCTOR - 2014Seattle Magazine 2014
Seattle Magazine Top Doctor - 2013Seattle Magazine 2013


Presentations TitleEventLocationDate
CARRA and PRCSG – Distinct Roles, Issues in Pediatric Clinical Trials ConsortiaACR Innovative Therapies in Autoimmune Diseases ConferenceWashington DCJan. 1, 2009
Biologic Therapies for Juvenile Idiopathic ArthritisRheumatology Grand Rounds, Hospital for Special SurgeryNYC, New YorkJan. 1, 2009
Pediatric Rheumatology PerspectiveFDA Public Workshop: Developing a Consolidated Pediatric Rheumatology Observational RegistryBethesda, MDJan. 1, 2009
Disease Suppression without Steroids in Systemic JIAEuropean League Against Rheumatism Congress Copenhagen, DenmarkJan. 1, 2009

Research Funding

Grant TitleGrantorAmountAward Date
CARRA- Accelerating Toward an Evidence Based Culture in Pediatric RheumatologyNIH-NIAMS $09.01.0947,930.00
TREAT Follow-up StudyAmgen $338,125.00Nov. 7, 2009
Comparative Effectiveness Research in Pediatric Rheumatic Diseases: Leveraging CARRA for Improved Child Health NIH-NIAMS $994,839.00Sept. 1, 2009
Trial of Early Aggressive Therapy of Juvenile Idiopathic Arthritis (TREAT)NIH- NIAMS $193,417.00Sept. 1, 2009
Dynamics of Therapeutic Response within the TREAT trialNIH-NIAMS $15,284.00Sept. 1, 2009
STRIVE- Long term, multi-center, longitudinal post-marketing, observational registry of Humira in children with active Juvenile Idiopathic Arthritis. Per patient enrolled paymentsAbbott $per patient enrollmentMay 1, 2009
Dynamic Assessment in Multicenter Trials – Supplement to Expand Testing of Pediatrics PROMIS ToolNIH $15,000.00May 1, 2009
Randomized Placebo Phase study of Rilonacept in the Treatment of systemic juvenile idiopathic arthritisNIH-NIAMS $Per patient enrolled paymentsJuly 1, 2008
CARRA Enhanced Drug Safety Surveillance Study Pfizer $289,050.00Oct. 1, 2007
Early Aggressive Therapy in Juvenile Idiopathic Arthritis (TREAT)NIH – NIAMS $4,136,107.00Sept. 1, 2006
Private donation - To support research in Juvenile Rheumatoid Arthritis proceeds from endowmentPrivateJan. 1, 2004
National Collaborative Study of Stem Cell Transplantationn/a $unfundedMay 1, 1999

Primary Office

Seattle Children's
MA.7.110 - Rheumatology
4800 Sand Point Way NE
Seattle, WA 98105

Find a Doctor or Researcher

Find a Doctor or Researcher

Type the first or last name you are searching for or select a specialty.

Doctor or Researcher Name:

More search options